Showing results (1-10 of 8) with videos related to
Sort By:
Pageof 1
Addictive Behaviors|February 2, 2006
Maternal smoking during late pregnancy and offspring smoking behaviourM R Munafò, E P Wileyto, M F G Murphy, et al.The Pharmacogenomics Journal|December 19, 2012
APOE ɛ4, an Alzheimer's disease susceptibility allele, and smoking cessationR L Ashare, J H Karlawish, E P Wileyto, et al.Public Health Reports (Washington, D.C. : 1974)|March 13, 2002
Risk factors for lyme disease in Chester County, PennsylvaniaG Smith, E P Wileyto, R B Hopkins, et al.The Pharmacogenomics Journal|January 13, 2006
Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependenceJ P Dahl, C Jepson, R Levenson, et al.Clinical Pharmacology and Therapeutics|March 26, 2010
Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapyC Lerman, C Jepson, E P Wileyto, et al.Digestive Diseases and Sciences|December 25, 2002
Human esophageal cancer is distinguished from adjacent esophageal tissue by tissue cysteine concentrationsS M Evans, R Lew, M L Kochman, et al.Molecular Psychiatry|December 10, 2008
Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotypeJ Loughead, E P Wileyto, J N Valdez, et al.The Pharmacogenomics Journal|March 10, 2004
The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trialC Lerman, E P Wileyto, F Patterson, et al.Pageof 1